Oxford BioDynamics (LMQ) Financial Statements
Oxford BioDynamics Financial Overview
Oxford BioDynamics's market cap is currently $17.27M. The company's EPS TTM is $-0.00; its P/E ratio is -0.27; Oxford BioDynamics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.09M | $ 636.00K | $ 510.00K | $ 154.00K | $ 341.00K |
| Gross Profit | $ -6.15M | $ 289.00K | $ 266.00K | $ 116.00K | $ -557.00K |
| Operating Income | $ -10.66M | $ -12.89M | $ -11.03M | $ -8.60M | $ -7.51M |
| EBITDA | $ -9.80M | $ -10.27M | $ -9.84M | $ -6.16M | $ -6.43M |
| Net Income | $ -11.15M | $ -11.57M | $ -10.83M | $ -6.71M | $ -6.68M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.39M | $ 2.83M | $ 5.25M | $ 999.00K | $ 4.34M |
| Total Assets | $ 8.09M | $ 12.11M | $ 16.13M | $ 11.34M | $ 15.38M |
| Total Debt | $ 5.11M | $ 5.74M | $ 6.44M | $ 6.14M | $ 6.59M |
| Net Debt | $ 3.72M | $ 3.91M | $ 1.19M | $ 5.16M | $ 4.41M |
| Total Liabilities | $ 6.97M | $ 7.75M | $ 10.07M | $ 8.76M | $ 8.69M |
| Stockholders' Equity | $ 1.12M | $ 4.36M | $ 6.05M | $ 2.59M | $ 6.68M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.73M | $ -10.77M | $ -9.01M | $ -6.08M | $ -9.01M |
| Operating Cash Flow | $ -7.71M | $ -10.17M | $ -8.44M | $ -5.18M | $ -5.92M |
| Investing Cash Flow | $ 756.00K | $ -1.49M | $ -691.00K | $ 1.25M | $ 2.83M |
| Financing Cash Flow | $ 6.52M | $ 8.25M | $ 13.42M | $ 2.56M | $ -804.00K |
Currency in GBP